Medifast vs TH International

Medifast Inc and TH International Ltd are examined side by side to explain how their business models, financial performance, and market context compare. This page presents neutral, accessible information about strategy, revenue drivers, and industry positioning for both companies without recommendation or verdicts. Educational content, not financial advice.

About The Companies

Medifast (MED)

TH International (THCH)

TH International Ltd (THCH) is a small-cap company with a market capitalisation of about $80.78 million. Investors should begin with its core business — product lines, geographic reach and recent revenue trends — because small companies can shift strategy rapidly. Potential attractions include niche market exposure and growth optionality if management executes well; risks include limited liquidity, higher share price volatility and greater sensitivity to single-market or single-product setbacks. Financial disclosure quality, debt levels and cash flow are key to assess given the size. Valuation metrics may be volatile or not meaningful if earnings are inconsistent. For many retail investors THCH is a higher-risk holding suited to those comfortable with small-cap dynamics and doing thorough research. This summary is for general educational purposes only and is not personalised investment advice; values can rise and fall and past performance is not a reliable indicator of future returns.

Comparison Snapshot

Key Financial Metrics

MED

Metric

THCH

$135.85M

Market Cap

$74.80M

15.12%

Potential Profit

N/A

Hold

Analyst Rating

N/A

Which Baskets Do They Appear In?

No baskets available in this category

Which Baskets Do They Appear In?

No baskets available in this category

Investment Analysis

Medifast

MED

Pros

Medifast has a strong gross margin of over 72%, indicating efficient production and pricing strategies.
The company is repositioning itself towards metabolic health, which represents a potential growth opportunity.
Analyst price targets suggest a positive medium- to long-term outlook, with forecasts potentially exceeding $16 in the next year.

Considerations

Recent financial results show a significant 36.2% year-over-year decline in revenue and a net loss reported in Q3 2025.
There has been a 35% drop in active OPTAVIA coaches, indicating challenges in its core direct selling model.
Stock analysts have a mixed consensus with some recommending 'reduce' and others 'hold,' reflecting uncertainty in near-term performance.

TH International

THCH

Pros

TH International specializes in tea production and capitalises on the growing global demand for premium and specialty teas.
The company has established brands with strong market recognition in Asian and export markets.
Recent expansions in environmentally friendly packaging and sustainable sourcing bolster its appeal to eco-conscious consumers.

Considerations

TH International faces significant exposure to commodity price fluctuations, especially tea leaf costs, impacting margin stability.
Competition in the tea market is intense with numerous regional and international players affecting market share.
Economic slowdowns in key export regions could reduce demand, posing a risk to revenue growth.

Why invest with Nemo?

🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Comparisons

Medifast vs HF Foods

Medifast vs HF Foods: a stock comparison

Medifast vs TH International

About The Companies

Comparison Snapshot

Which Baskets Do They Appear In?

Which Baskets Do They Appear In?